4//SEC Filing
Moran Susan 4
Accession 0001415889-24-002852
CIK 0001825367other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:11 PM ET
Size
6.9 KB
Accession
0001415889-24-002852
Insider Transaction Report
Form 4
RayzeBio, Inc.RYZB
Moran Susan
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-01-22$3.24/sh+30,875$100,035→ 322,647 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-01-22−30,875→ 60,757 totalExercise: $3.24Exp: 2031-09-28→ Common Stock (30,875 underlying)
Footnotes (1)
- [F1]The option is subject to an early exercise provision and is immediately exercisable. 25% of the shares vested on September 29, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
RayzeBio, Inc.
CIK 0001825367
Entity typeother
Related Parties
1- filerCIK 0001835225
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 6:11 PM ET
- Size
- 6.9 KB